Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Anticancer activity and targeted delivery of metal-based drugs

Großformatiges Paperback. Klappenbroschur.
BuchKartoniert, Paperback
284 Seiten
Englisch
In this thesis, promising representatives of approved and novel metal-based drugs containing arsenic, ruthenium and platinum were analyzed for their anticancer activity. Strategies such as drug combinations, polymeric nanoformulations, and drug structure modifications were employed to increase their anticancer activity, overcome drug resistance, and reduce side effects. Summarizing, these studies suggest that metal-based drugs are promising anticancer therapeutics that can be further improved in their anticancer activity by structural modifications, combination with targeted therapeutics, as well as application of biodegradable drug carriers for targeted delivery.mehr

Produkt

KlappentextIn this thesis, promising representatives of approved and novel metal-based drugs containing arsenic, ruthenium and platinum were analyzed for their anticancer activity. Strategies such as drug combinations, polymeric nanoformulations, and drug structure modifications were employed to increase their anticancer activity, overcome drug resistance, and reduce side effects. Summarizing, these studies suggest that metal-based drugs are promising anticancer therapeutics that can be further improved in their anticancer activity by structural modifications, combination with targeted therapeutics, as well as application of biodegradable drug carriers for targeted delivery.
Details
ISBN/GTIN978-3-8381-5380-3
ProduktartBuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2017
Erscheinungsdatum10.05.2017
Seiten284 Seiten
SpracheEnglisch
Artikel-Nr.43359802
Rubriken
GenreMedizin

Autor

Kryeziu, KushtrimKushtrim Kryeziu was born in Kapre, Kosovo in 1985. After graduation in genetics and microbiology at the University of Vienna he obtained his PhD at the Medical University of Vienna on malignant diseases. Kushtrim is a posdoctoral fellow at the Institute for Cancer Research in Oslo, Norway.
Weitere Artikel von
Kryeziu, Kushtrim